Skip to main content
MEDINET Co., Ltd. logo

MEDINET Co., Ltd. — Investor Relations & Filings

Ticker · 2370 ISIN · JP3920990003 T Manufacturing
Filings indexed 64 across all filing types
Latest filing 2022-08-12 Report Publication Anno…
Country JP Japan
Listing T 2370

About MEDINET Co., Ltd.

https://www.medinet-inc.co.jp/english/

MEDINET Co., Ltd. is a Contract Development and Manufacturing Organization (CDMO) specializing in regenerative medicine and cell therapy. The company provides comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and process development to manufacturing and commercial launch. Its services encompass technology transfer, quality control, and quality assurance for regenerative medical products, investigational products, and specified cell products. MEDINET operates an advanced cell processing facility (CPF) designed to comply with international standards such as GCTP, leveraging extensive experience since 1999 to support clients in developing and manufacturing their cellular therapies.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, which accompanies a Quarterly Report (Shihanki Hokokusho). Since the document is a formal regulatory filing confirming the accuracy of the quarterly report and is not the quarterly report itself, it falls under the category of Regulatory Filings.
2022-08-12 Japanese
四半期報告書-第27期第3四半期(令和4年4月1日-令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第3四半期報告書) for the third quarter of the 27th fiscal period of Medinet Co., Ltd. It contains detailed financial statements (balance sheet, income statement), management analysis, and auditor information, which are characteristic of an Interim/Quarterly Report (IR). It is not an announcement of a report (RPA) because it contains the full financial data and disclosures required by the Financial Instruments and Exchange Act. 9M 2022
2022-08-12 Japanese
四半期報告書-第27期第2四半期(令和4年1月1日-令和4年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Medinet Co., Ltd. with the Kanto Local Finance Bureau on May 13, 2022. It contains detailed financial statements, management analysis of financial conditions, and operational results for the second quarter of the 27th fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-05-13 Japanese
四半期報告書-第27期第1四半期(令和3年10月1日-令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Medinet Co., Ltd., covering the period from October 1, 2021, to December 31, 2021. It contains detailed financial statements (Balance Sheet, Profit and Loss Statement), management analysis, and notes to the financial statements, which are characteristic of an Interim/Quarterly Report. It is not an announcement of a report, but the report itself. Q1 2022
2022-02-14 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies an Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the categories of the report itself or other specific corporate actions, it is classified as a Regulatory Filing (RNS). FY 2021
2021-12-16 Japanese
内部統制報告書-第26期(令和2年10月1日-令和3年9月30日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. Since this is a specific regulatory filing required by law that does not fit into the categories of Annual Reports (10-K), Earnings Releases (ER), or other specific financial reporting categories, it is best classified as a Regulatory Filing (RNS).
2021-12-16 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.